{"id":"NCT01103284","sponsor":"Andromeda Biotech Ltd.","briefTitle":"Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults","officialTitle":"A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Clinical Efficacy and Safety of DiaPep277 in Newly Diagnosed Type 1 Diabetes Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-04","primaryCompletion":"2014-10","completion":"2014-10","firstPosted":"2010-04-14","resultsPosted":"2016-05-26","lastUpdate":"2016-05-26"},"enrollment":475,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 1 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"DiaPep277","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"DiaPep277","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will look at the treatment effect of DiaPep277 on preservation of beta-cell function, as defined by meal-stimulated secretion of insulin. DiaPep277 is a peptide that changes the way the immune system behaves, stopping its attack on the beta-cells.\n\nAdults (\\>20 years) with newly diagnosed (\\<6 months) type 1 diabetes will be treated with 10 injections of DiaPep277 or Placebo over a 2-year treatment and follow-up period.","primaryOutcome":{"measure":"Change From Baseline in Glucagon-Stimulated C-Peptide AUC at 24 Months","timeFrame":"Baseline and 24 months","effectByArm":[{"arm":"DiaPep277","deltaMin":-5.2,"sd":0.27},{"arm":"Placebo","deltaMin":-4.83,"sd":0.3}],"pValues":[{"comp":"OG000 vs OG001","p":"0.33"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":75,"countries":["United States","Austria","Belarus","Canada","Czechia","Finland","Germany","Hungary","Israel","Italy","Lithuania","Poland","Russia","Spain"]},"refs":{"pmids":["18422727","17024692","17103487","17124720","19267355","11734230","17130576","16893923","20034363"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":236},"commonTop":["Nasopharyngitis","Headache","Injection site pain","Influenza","Upper respiratory tract infection"]}}